Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: A Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI)
- Bulluck H.
- Paradies V.
- Barbato E.
- Baumbach A.
- Botker H. E.
- Capodanno D.
- De Caterina R.
- Cavallini C.
- Davidson S. M.
- Feldman D. N.
- Ferdinandy P.
- Gili S.
- Gyongyosi M.
- Kunadian V.
- Ooi S. -Y.
- Madonna R.
- Marber M.
- Mehran R.
- Ndrepepa G.
- Perrino C.
- Schupke S.
- Silvain J.
- Sluijter J. P. G.
- Tarantini G.
- Toth G. G.
- Van Laake L. W.
- Von Birgelen C.
- Zeitouni M.
- Jaffe A. S.
- Thygesen K.
- Hausenloy D. J.
DOIAbstract
A substantial number of chronic coronary syndrome (CCS) patients undergoing percutaneous coronary intervention (PCI) experience periprocedural myocardial injury or infarction. Accurate diagnosis of these PCI-related complications is required to guide further management given that their occurrence may be associated with increased risk of major adverse cardiac events (MACE). Due to lack of scientific data, the cut-off thresholds of post-PCI cardiac troponin (cTn) elevation used for defining periprocedural myocardial injury and infarction, have been selected based on expert consensus opinions, and their prognostic relevance remains unclear. In this Consensus Document from the ESC Working Group on Cellular Biology of the Heart and European Asso...
Add to ORKG